Sechenov School
Home › Pharmacology › M-Cholinomimetics

M-Cholinomimetics

*M-cholinomimetica*

For medical students2 min readUpdated 2026-10-10

M-cholinomimetics are a group of pharmacological agents that selectively stimulate muscarinic receptors (M-receptors) on the membranes of cells receiving parasympathetic innervation. By interacting with these receptors, they reproduce the effects of parasympathetic nervous system activation, affecting smooth muscle, the heart, and exocrine glands.

Site of actionMetabotropic G protein-coupled receptors ($M_1$–$M_5$).
Prototype compoundMuscarine (a toxic alkaloid, not used clinically).
Chemical structureDivided into tertiary and quaternary ammonium compounds.
Specific antidoteAtropine (a typical muscarinic antagonist).

Signal Transduction Mechanism

Muscarinic receptors belong to metabotropic receptors, meaning they are coupled with G proteins. There are five subtypes in total ($M_1$–$M_5$), of which the first three are the most studied.

Let us trace the reaction cascade using cardiac $M_2$ receptors as an example:

  1. The substance binds to receptors on the cardiomyocyte membrane.
  2. The inhibitory $G_i$ protein is activated.
  3. The enzyme adenylyl cyclase is inhibited.
  4. Intracellular synthesis of cyclic adenosine monophosphate (cAMP) decreases.
  5. The activity of cAMP-dependent protein kinases drops.
  6. Protein phosphorylation is impaired, ultimately leading to the inhibition of cardiac function (development of bradycardia).

Muscarine and Mushroom Poisoning

The prototype of the group is muscarine, an alkaloid found in poisonous mushrooms. It excites all muscarinic receptor subtypes, but due to its structure (quaternary nitrogen), it does not cross the blood-brain barrier (BBB) and does not affect the central nervous system. It is used exclusively in experimental pharmacology and toxicology.

Amanita mushroom poisoning consists of two components:

Chemical Classification

The ability of drugs to cross cellular barriers (including the BBB) directly depends on their chemical structure:

Clinical Application of Synthetic Agents

Synthetic analogs are used in medical practice because they possess more predictable action and a better safety profile.

Aceclidine (Aceclidinum) Used topically in ophthalmology to lower intraocular pressure in glaucoma (effects last up to 6 hours, but may cause conjunctival irritation). Systemically (orally or parenterally), it is prescribed for intestinal and urinary bladder atony, as well as to increase uterine tone and stop postpartum hemorrhage. It is less toxic than pilocarpine.

Bethanechol (Bethanechol) Has a systemic activity profile similar to aceclidine. The main indication is the relief of intestinal and urinary bladder atony.

Cevimeline (Cevimeline) A predominantly $M_3$ receptor agonist (and partially $M_1$). The main effect is powerful stimulation of the salivary glands. It is prescribed for xerostomia (dry mouth), for example, in Sjögren's syndrome or post-radiation therapy.

Contraindications and Adverse Effects

Overdose or systemic effects of m-cholinomimetics cause hypersalivation, diarrhea, drop in blood pressure, and smooth muscle spasms.

Based on their mechanism of action, these drugs are strictly contraindicated in:

Mnemonic

The effects of m-cholinomimetics are easy to remember by the rule "everything flows, everything narrows, everything slows down": the secretion of all glands increases (saliva, sweat, gastric juice), smooth muscles of hollow organs and bronchi constrict, and the heart works slower.

Frequently asked questions

In which organs and tissues are M1, M2, and M3 muscarinic receptors predominantly localized?

Muscarinic receptors are localized on the cells of target organs of the parasympathetic nervous system.

  • M1 receptors — structures involved in regulating HCl secretion in the stomach.
  • M2 receptors — cardiomyocyte membranes in the heart.
  • M3 receptors — smooth muscle cells of internal organs: bronchi, stomach, intestines, urinary bladder, biliary tract; also associated with the stimulation of salivary gland secretion.
Through what mechanism do m-cholinomimetics reduce intraocular pressure in glaucoma?

The mechanism of reducing intraocular pressure depends on the form of glaucoma and is due to improved outflow of intraocular fluid.

  • Angle-closure glaucoma — pupil constriction (miosis) leads to thinning of the iris and opening of the anterior chamber angle, providing access to the spaces of Fontana and the canal of Schlemm.
  • Open-angle glaucoma — contraction of the ciliary muscle causes tension on the trabeculae of the pectinate ligament, mechanically widening the spaces of Fontana and improving outflow through the trabecular meshwork.
What is the main difference between tertiary and quaternary m-cholinomimetics?

Tertiary amines (e.g., aceclidine) do not have a permanent ionic charge. This allows them to penetrate biological membranes much better compared to quaternary compounds.

Why is aceclidine used in obstetrics?

Aceclidine stimulates myometrial muscarinic receptors, increasing uterine tone. This property is used to stop uterine bleeding in the postpartum period.

Go deeper

More topics in Pharmacology

BenzocaineArtemisininPraziquantel: Mechanism, Spectrum and Clinical UseStrophanthine and CorglyconMethyldopaVitamin KHormonal Drugs for Pregnancy MaintenanceTopical Antiherpetic AgentsMolsidomineActive TransportIntracellular ReceptorsToxic Drug Effects and OverdosePharmacology →